Effectiveness and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections in “Real Life”
Author(s) -
Frank Dusemund
Publication year - 2012
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2012.770
Subject(s) - medicine , procalcitonin , pneumonia , bronchitis , respiratory tract infections , odds ratio , cefixime , antibiotics , community acquired pneumonia , exacerbation , chronic bronchitis , lower respiratory tract infection , intensive care medicine , respiratory system , cephalosporin , sepsis , biology , microbiology and biotechnology
In controlled studies, procalcitonin (PCT) has safely and effectively reduced antibiotic drug use for lower respiratory tract infections (LRTIs). However, controlled trial data may not reflect real life.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom